Innoviva Sells 15% Economic Stake in Theravance Respiratory Company to Royalty Pharma for approximately $282 million plus full ownership of existing equity investments and the potential for $50 million milestone payment  https://t.co/89s5xOWQ6H  https://t.co/7BNqNTQf0Y